|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.07 USD | -2.99% |
|
-8.37% | +34.27% |
| Market Cap | 526M 462M 430M 395M 741M 50.7B 753M 5.11B 1.99B 24.92B 1.98B 1.93B 86.17B | P/E 2026 * |
-2.53x | P/E 2027 * | -2.98x |
|---|---|---|---|---|---|
| Enterprise Value | 299M 263M 244M 224M 421M 28.79B 428M 2.9B 1.13B 14.15B 1.12B 1.1B 48.94B | EV / Sales 2026 * |
25.8x | EV / Sales 2027 * | 18.5x |
| Free-Float |
96.79% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: 4D Molecular Therapeutics, Inc.
| 1 day | -2.99% | ||
| 1 week | -8.37% | ||
| Current month | -24.29% | ||
| 1 month | -12.59% | ||
| 3 months | +7.13% | ||
| 6 months | +26.51% | ||
| Current year | +34.27% |
| 1 week | 9.9 |  | 11.96 |
| 1 month | 9.9 | | 14 |
| Current year | 6.96 | | 14 |
| 1 year | 4.27 | | 14 |
| 3 years | 2.24 | | 36.25 |
| 5 years | 2.24 | | 36.25 |
| 10 years | 2.24 | | 55.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
Theresa Janke
COO | Chief Operating Officer | 51 | 2018-03-31 |
David Kirn
CEO | Chief Executive Officer | 64 | 2013-09-11 |
Scott Bizily
CMP | Compliance Officer | 54 | 2021-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
David Kirn
CHM | Chairman | 64 | 2013-09-11 |
Charles Theuer
BRD | Director/Board Member | 62 | 2015-11-30 |
Jacob Chacko
BRD | Director/Board Member | 47 | 2019-02-28 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/10/26 | Sell | Founder | -15,725 | 0.0301% | ||
| 6/30/26 | Fiscal year | Compliance Officer | 19,698 | 0.0377% | ||
| 6/23/26 | Fiscal year | Compliance Officer | 29,430 | 0.0563% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.99% | -8.37% | +120.35% | -44.09% | 526M | |
| +1.07% | -3.49% | -3.35% | +10.44% | 46.86B | |
| +0.25% | +1.65% | +399.22% | +634.87% | 40.23B | |
| -0.27% | +4.45% | +11.81% | +65.64% | 36.23B | |
| +0.35% | +0.87% | +4.46% | -10.16% | 34.72B | |
| +3.14% | +1.02% | +4.76% | +40.92% | 27.89B | |
| -0.73% | +11.84% | +34.39% | +134.36% | 16.79B | |
| +0.47% | -2.74% | - | - | 16.74B | |
| +0.42% | -5.52% | -3.43% | +9.03% | 13.12B | |
| -2.68% | -2.49% | -11.36% | -33.61% | 12.7B | |
| Average | -0.10% | -0.09% | +61.87% | +89.71% | 24.58B | |
| Weighted average by Cap. | +0.47% | +0.89% | +74.52% | +135.86% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 11.6M 10.19M 9.47M 8.69M 16.34M 1.12B 16.59M 113M 43.96M 549M 43.55M 42.61M 1.9B | 17.51M 15.38M 14.3M 13.12M 24.66M 1.69B 25.04M 170M 66.35M 829M 65.73M 64.31M 2.87B |
| Net income | -277M -243M -226M -207M -390M -26.65B -396M -2.68B -1.05B -13.1B -1.04B -1.02B -45.31B | -282M -248M -230M -211M -397M -27.14B -403M -2.73B -1.07B -13.35B -1.06B -1.04B -46.14B |
| Net Debt | -227M -200M -186M -170M -320M -21.91B -325M -2.21B -862M -10.77B -854M -836M -37.24B | -203M -178M -166M -152M -286M -19.54B -290M -1.97B -769M -9.61B -762M -745M -33.21B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-24 | US$10.07 | -2.99% | 682,426 |
| 26-07-23 | US$10.38 | -5.29% | 567,285 |
| 26-07-22 | US$10.96 | -3.65% | 717,183 |
| 26-07-21 | US$11.38 | +2.57% | 1,025,540 |
| 26-07-20 | US$11.09 | +0.91% | 821,598 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- FDMT Stock
Select your edition
All financial news and data tailored to specific country editions
